Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand

被引：5
|
作者：
Wilson, Nick [1 ]
Morgan, Jane [2 ]
Baker, Michael G. [1 ]
机构：
[1] Univ Otago, Wellington 6021, New Zealand
[2] Waikato Dist Hlth Board, Sexual Hlth Serv, Hamilton, New Zealand
来源：
SEXUALLY TRANSMITTED INFECTIONS | 2014年 / 90卷 / 02期
关键词：
GENITAL WARTS; HPV; VACCINATION; PREVENTION; PUBLIC HEALTH;
D O I：
10.1136/sextrans-2013-051037
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [1] Realising the promise of HPV vaccination - data from the national cervical screening and vaccination registers demonstrates the impact of HPV vaccination in Aotearoa New Zealand
    Sykes, Peter
    Innes, Carrie
    Simcock, Bryony
    Lawton, Beverley
    Williman, Jonathan
    JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND, 2025,
  • [2] Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
    Smith, Megan A.
    Liu, Bette
    McIntyre, Peter
    Menzies, Robert
    Dey, Aditi
    Canfell, Karen
    BMC INFECTIOUS DISEASES, 2016, 16
  • [3] Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
    Megan A. Smith
    Bette Liu
    Peter McIntyre
    Robert Menzies
    Aditi Dey
    Karen Canfell
    BMC Infectious Diseases, 16
  • [4] Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
    Boiron, L.
    Joura, E.
    Largeron, N.
    Prager, B.
    Uhart, M.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [5] Introduction of a National HPV vaccination program into Bhutan
    Dorji, Tandin
    Tshomo, Ugyen
    Phuntsho, Sangay
    Tamang, Tshewang Dorji
    Tshokey, Tshokey
    Baussano, Iacopo
    Franceschi, Silvia
    Clifford, Gary
    VACCINE, 2015, 33 (31) : 3726 - 3730
  • [6] Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand
    Smith, Megan A.
    Hall, Michaela
    Lew, Jie-Bin
    Canfell, Karen
    VACCINE, 2018, 36 (42) : 6314 - 6324
  • [7] National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States
    Durham, David P.
    Ndeffo-Mbah, Martial L.
    Skrip, Laura A.
    Jones, Forrest K.
    Bauch, Chris T.
    Galvani, Alison P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (18) : 5107 - 5112
  • [8] Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program
    Baldur-Felskov, Birgitte
    Dehlendorff, Christian
    Junge, Jette
    Munk, Christian
    Kjaer, Susanne K.
    CANCER CAUSES & CONTROL, 2014, 25 (07) : 915 - 922
  • [9] National prevalence of gout derived from administrative health data in Aotearoa New Zealand
    Winnard, Doone
    Wright, Craig
    Taylor, William J.
    Jackson, Gary
    Karu, Leanne Te
    Gow, Peter J.
    Arroll, Bruce
    Thornley, Simon
    Gribben, Barry
    Dalbeth, Nicola
    RHEUMATOLOGY, 2012, 51 (05) : 901 - 909
  • [10] Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia
    Gertig, Dorota M.
    Brotherton, Julia M. L.
    Saville, Marion
    SEXUAL HEALTH, 2011, 8 (02) : 171 - 178
12345